Related Experiment Videos

The influence of genetic and cardiovascular risk factors on the CADASIL phenotype

Sumeet Singhal1, Steve Bevan, Tom Barrick

  • 1Clinical Neuroscience, St George's Hospital Medical School, London, UK.

Insights

Clinical variability in cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL) is not linked to mutation site. Smoking and high homocysteine levels are associated with stroke and migraine onset, respectively.

Area of Science:

  • Neurology
  • Genetics
  • Vascular Disease

Background:

  • Cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL) presents with variable clinical features.
  • The reasons for this phenotypic variability remain unclear, with potential influences from mutation site and modulating factors.

Purpose of the Study:

  • To investigate the relationship between phenotype, mutation site, apoE genotype, and cardiovascular risk factors in a large cohort of CADASIL patients.
  • To assess disease severity using MRI lesion volume.

Main Methods:

  • Recruited 127 CADASIL cases from 65 families with 17 distinct mutations.
  • Assessed clinical features, MRI lesion volume (Scheltens scale and quantitative), apoE genotype, and cardiovascular risk factors.
  • Analyzed associations between genotype, risk factors, and clinical/radiological phenotypes.

Main Results:

  • No association found between mutation site and the onset or presence of stroke, migraine, dementia, or dependency.
  • Smoking was independently associated with an earlier age of stroke onset.
  • Elevated homocysteine levels were linked to migraine and an earlier onset of migraine.

Conclusions:

  • No genotype-phenotype correlation was observed for Notch 3 mutations in CADASIL.
  • Modulating factors, such as smoking and homocysteine levels, significantly influence the clinical phenotype.
  • Smoking increases stroke risk, while high homocysteine is associated with increased migraine risk in CADASIL.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...